Diversified Trust Co Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Diversified Trust Co lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 15.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 49,356 shares of the company’s stock after acquiring an additional 6,421 shares during the period. Diversified Trust Co’s holdings in HCA Healthcare were worth $14,814,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. FMR LLC boosted its position in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after buying an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after buying an additional 41,190 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of HCA Healthcare by 12.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after acquiring an additional 143,995 shares in the last quarter. Finally, Darsana Capital Partners LP increased its position in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $10.27 on Tuesday, reaching $307.19. The company’s stock had a trading volume of 494,654 shares, compared to its average volume of 1,026,586. The company has a market capitalization of $77.81 billion, a P/E ratio of 13.79, a PEG ratio of 1.21 and a beta of 1.64. The stock has a 50-day moving average price of $325.72 and a 200-day moving average price of $354.69. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 52-week low of $276.50 and a 52-week high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.86%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of research reports. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday. Morgan Stanley lowered their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Finally, TD Cowen reduced their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.